Skip to main content

CollPlant Biotechnologies Ltd. (CLGN)

NASDAQ: CLGN · Delayed Price · USD
16.84 0.14 (0.84%)
Sep 23, 2021 3:17 PM EDT - Market open
Market Cap171.31M
Revenue (ttm)19.90M
Net Income (ttm)4.88M
Shares Out10.26M
EPS (ttm)0.51
PE Ratio33.35
Forward PE8.42
Dividendn/a
Ex-Dividend Daten/a
Volume2,972
Open16.65
Previous Close16.70
Day's Range16.65 - 17.20
52-Week Range15.98 - 23.49
Beta0.78
AnalystsBuy
Price Target13.02 (-22.7%)
Est. Earnings Daten/a

About CLGN

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants that are used for the regeneration of breast tissu...

IndustryBiotechnology
Founded2004
CEOYehiel Tal
Employees52
Stock ExchangeNASDAQ
Ticker SymbolCLGN
Full Company Profile

Financial Performance

In 2020, CLGN's revenue was $6.14 million, an increase of 164.75% compared to the previous year's $2.32 million. Losses were -$5.77 million, -48.28% less than in 2019.

Financial Statements

Analyst Forecast

According to one analyst, the rating for CLGN stock is "Buy" and the 12-month stock price forecast is 13.02.

Price Target
$13.02
(-22.70% downside)
Analyst Consensus: Buy

News

CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)

REHOVOT, Israel, Sept. 9, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ ...

2 weeks ago - PRNewsWire

CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September

REHOVOT, Israel, Sept. 7, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ ...

2 weeks ago - PRNewsWire

CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors

REHOVOT, Israel, Aug. 19, 2021 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ m...

1 month ago - PRNewsWire

Recap: CollPlant Biotechnologies Q2 Earnings

Shares of CollPlant Biotechnologies (NASDAQ:CLGN) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share fell 25.00% year over year to ($0.25), which missed the estim...

1 month ago - Benzinga

CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results

REHOVOT, Israel, Aug. 19, 2021 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ m...

1 month ago - PRNewsWire

CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Or...

REHOVOT, Israel, Aug. 16, 2021 /PRNewswire/ - CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ ma...

1 month ago - PRNewsWire

Why 3D Systems, CollPlant BioTechnologies, and Stratasys Stocks Soared Today

Five months ago, 3D Systems promised to expand into the "nascent industry" of printing entire human body parts. Today, it's doing just that.

Other symbols:DDDSSYS
3 months ago - The Motley Fool

CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs

REHOVOT, Israel, June 4, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced today the uplisting of its ordinary shares to the Nasdaq Global Select Ma...

3 months ago - PRNewsWire

CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million

REHOVOT, Israel, May 27, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the first quarter ended March 31, 2021 and pr...

3 months ago - PRNewsWire

CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs

REHOVOT, Israel, May 25, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasdaq Glo...

3 months ago - PRNewsWire

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) Outpaces Stock Market Gains: What You Should Know

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) closed at $14.68 in the latest trading session, marking a +1.91% move from the prior day.

4 months ago - Zacks Investment Research

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) Stock Moves -0.22%: What You Should Know

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) closed at $13.77 in the latest trading session, marking a -0.22% move from the prior day.

4 months ago - Zacks Investment Research

CollPlant (CLGN) to Report Q1 Earnings: What's in the Cards?

CollPlant (CLGN) is set to report earnings and revenues, and provide product updates when it releases first-quarter 2021 results.

4 months ago - Zacks Investment Research

Is CollPlant Biotechnologies Ltd. Sponsored (CLGN) Stock Outpacing Its Medical Peers This Year?

Is (CLGN) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors

REHOVOT, Israel, March 29, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced the appointment of Hugh Evans to its Board of Directors, increas...

5 months ago - PRNewsWire

CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020

REHOVOT, Israel, March 26, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the full year ended December 31, 2020 and p...

5 months ago - PRNewsWire

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) Dips More Than Broader Markets: What You Should Know

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) closed at $12.26 in the latest trading session, marking a -1.84% move from the prior day.

5 months ago - Zacks Investment Research

Has CollPlant Biotechnologies Ltd. Sponsored (CLGN) Outpaced Other Medical Stocks This Year?

Is (CLGN) Outperforming Other Medical Stocks This Year?

6 months ago - Zacks Investment Research

6 Beaten Down Stocks with Solid Growth Potential

Are you going to sit around to try and price a bottom or are you going to grab stocks that look obviously cheap today?

Other symbols:CRUSIMMRSPHSTFC
6 months ago - Zacks Investment Research

CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference

REHOVOT, Israel, March 4, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced that Mr. Yehiel Tal, Chief Executive Officer of CollPlant, will p...

6 months ago - PRNewsWire

Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants

REHOVOT, Israel, Feb. 25, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on February 24, 2021 it received a notice fro...

6 months ago - PRNewsWire

CollPlant Issues Letter to Shareholders

REHOVOT, Israel, Feb. 18, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) today announced the following letter from its Chief Executive Officer, Yehiel Tal, to its shareholders. Dear share...

7 months ago - PRNewsWire

CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares

REHOVOT, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies (NASDAQ:CLGN), today announced that it has closed the previously announced registered direct offering for the purchase and sa...

7 months ago - GlobeNewsWire

Why Corvus Pharmaceuticals, Prothena, CollPlant Are Moving Today

Corvus Pharmaceuticals (NASDAQ: CRVS) shares are trading lower Friday after the company priced its 8.571 million share common stock offering at $3.50 per share. Corvus Pharmaceuticals Inc is a clinical-...

Other symbols:CRVSPRTA
7 months ago - Benzinga

CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares

REHOVOT, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies (NASDAQ:CLGN), today announced that it has entered into definitive agreements with several healthcare-focused and other insti...

7 months ago - GlobeNewsWire